Smoking Cessation
1,080
87
121
746
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
289 trials with published results (27%)
Research Maturity
746 completed trials (69% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.4%
47 terminated out of 1080 trials
94.1%
+7.5% vs benchmark
16%
172 trials in Phase 3/4
39%
289 of 746 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 746 completed trials
Clinical Trials (1080)
WeChat Quit Coach Pilot Study
Smoking Cessation Program for Lao People With HIV
Telegram Messenger Support for Smoking Cessation After Heart Attack
Rural Smoking Cessation
Adaptive Mobile Interventions to Reduce Cancer Risk Behaviors
Trial of Varenicline With Nicotine Lozenges and a Smartphone Medication Adherence Intervention for Smoking Cessation
Smoking Cessation Intervention Including Health Navigators to Address Unmet Social Needs of Parents Who Smoke
Pain and Smoking Study 2
Precision Treatment to Promote Smoking Cessation and Survival in Oncology Patients
Impact of Smoking Cessation Duration on Postoperative Complications in Lung Cancer Surgery
Mobile Contingency Management for Smoking Cessation
My Path to Quit Tobacco
Construal Level as a Novel Pathway for Affect Regulation and Cancer Control
Multi-Site Trial of Tirzepatide for Smoking Cessation
PARQuit Smoking Cessation Intervention for Adults With Serious Mental Illness
Acceptability of Mobile Applications (Apps) to Enhance Smoking Cessation in a Clinical Tobacco Treatment Program - A Pilot Study
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
Varenicline and Accelerated Transcranial Magnetic Stimulation (TMS) for Quitting Nicotine Use (Pilot Study)
CONNECT Cancer Survivors With Tobacco Treatment
Salvation Army Tobacco Quit Line Referral Implementation Trial